Siga Technologies INC Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Siga Technologies INC (SIGA) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $4.16 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $4.16K, a 84.05% decline year-over-year.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $581.00K, a 249.59% increase year-over-year.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $241.46K, a 14.56% decline year-over-year.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $433.76K, a 45.77% decline from fiscal 2024.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $799.89K, a 272.40% increase from fiscal 2023.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $214.79K, a 1613.83% increase from fiscal 2022.
- Siga Technologies INC share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $12.53K, a 92.79% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month as first filed | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.16K 10-Q · filed 2026-08-06 | $585.16K 10-Q · filed 2026-08-06 | $585.16K derived: sum of 3 quarters · filed 2026-08-06 | $826.62K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $581.00K 10-Q · filed 2026-05-07 | $581.00K derived: sum of 2 quarters · filed 2026-05-07 | $822.45K derived: sum of 3 quarters · filed 2026-05-07 | $848.57K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $241.46K derived: sum of 2 quarters · filed 2026-03-10 | $267.57K derived: sum of 3 quarters · filed 2026-08-06 | $433.76K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $241.46K 10-Q · filed 2025-11-06 | $267.57K derived: sum of 2 quarters · filed 2026-08-06 | $433.76K 10-Q · filed 2025-11-06 | $595.52K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $26.11K 10-Q · filed 2026-08-06 | $192.31K 10-Q · filed 2026-08-06 | $354.06K derived: sum of 3 quarters · filed 2026-08-06 | $636.66K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $166.19K 10-Q · filed 2026-05-07 | $327.95K derived: sum of 2 quarters · filed 2026-05-07 | $610.55K derived: sum of 3 quarters · filed 2026-05-07 | $610.55K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $161.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $444.36K derived: sum of 2 quarters · filed 2026-03-10 | $444.36K derived: sum of 3 quarters · filed 2026-03-10 | $799.89K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $282.60K 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2024-11-07 | $282.60K derived: sum of 2 quarters · filed 2025-11-06 | $638.14K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $355.54K 10-Q · filed 2025-08-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $214.79K derived: sum of 3 quarters · filed 2026-03-10 | $214.79K 10-K · filed 2026-03-10 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $214.79K derived: sum of 2 quarters · filed 2024-11-07 | $214.79K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $214.79K 10-Q · filed 2024-08-01 | $214.79K 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $12.53K 10-K · filed 2025-03-11 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $12.53K 10-Q · filed 2023-11-07 | $12.53K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $12.53K 10-Q · filed 2023-08-08 | $12.53K derived: sum of 3 quarters · filed 2024-03-12 | $173.09K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-03-31 | $12.53K 10-Q · filed 2023-05-04 | $12.53K derived: sum of 2 quarters · filed 2024-03-12 | $173.09K derived: sum of 3 quarters · filed 2024-03-12 | $173.09K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $160.56K derived: sum of 2 quarters · filed 2024-03-12 | $160.56K derived: sum of 3 quarters · filed 2024-03-12 | $173.92K 10-K · filed 2024-03-12 | |
| 2021-09-30 | $160.56K 10-Q · filed 2022-11-03 | $160.56K derived: sum of 2 quarters · filed 2022-11-03 | $173.92K 10-Q · filed 2022-11-03 | $173.92K derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $13.36K 10-Q · filed 2022-08-04 | $13.37K derived: sum of 3 quarters · filed 2023-03-02 | $187.63K derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-03-31 | $13.36K 10-Q · filed 2022-05-05 | $13.37K derived: sum of 2 quarters · filed 2023-03-02 | $187.63K derived: sum of 3 quarters · filed 2023-03-02 | $187.63K derived: sum of 4 quarters · filed 2023-03-02 | |
| 2020-12-31 | $7.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $174.27K derived: sum of 2 quarters · filed 2023-03-02 | $174.27K derived: sum of 3 quarters · filed 2023-03-02 | $184.02K 10-K · filed 2023-03-02 | |
| 2020-09-30 | $174.26K 10-Q · filed 2021-11-04 | $174.26K derived: sum of 2 quarters · filed 2021-11-04 | $184.01K 10-Q · filed 2021-11-04 | $1.16M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $9.75K 10-Q · filed 2021-08-05 | $986.51K derived: sum of 3 quarters · filed 2022-03-03 | $1.13M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-03-31 | $9.75K 10-Q · filed 2021-05-06 | $986.51K derived: sum of 2 quarters · filed 2022-03-03 | $1.13M derived: sum of 3 quarters · filed 2022-03-03 | $1.13M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2019-12-31 | $976.77K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.12M derived: sum of 2 quarters · filed 2022-03-03 | $1.12M derived: sum of 3 quarters · filed 2022-03-03 | $1.18M 10-K · filed 2022-03-03 | |
| 2019-09-30 | $143.22K 10-Q · filed 2020-11-05 | $143.22K derived: sum of 2 quarters · filed 2020-11-05 | $199.81K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $56.59K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $56.59K 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | $4.07M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |